Next Article in Journal
Comparison of Losartan and Furosemide Interaction with HSA and Their Influence on HSA Antioxidant Potential
Next Article in Special Issue
A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block
Previous Article in Journal
Study of Antibodies to Influenza Neuraminidase N2
Previous Article in Special Issue
A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury
 
 
Review

Article Versions Notes

Pharmaceuticals 2022, 15(5), 497; https://doi.org/10.3390/ph15050497
Action Date Notes Link
article xml file uploaded 19 April 2022 14:53 CEST Original file -
article xml uploaded. 19 April 2022 14:53 CEST Update https://www.mdpi.com/1424-8247/15/5/497/xml
article pdf uploaded. 19 April 2022 14:53 CEST Version of Record https://www.mdpi.com/1424-8247/15/5/497/pdf
article html file updated 19 April 2022 14:54 CEST Original file -
article html file updated 2 August 2022 19:41 CEST Update https://www.mdpi.com/1424-8247/15/5/497/html
Back to TopTop